Evidence map›Paper›PMID 25122042›Full record

ArticleJournal of psychopharmacology (Oxford, England)2014

Potentiation of latent inhibition by haloperidol and clozapine is attenuated in Dopamine D2 receptor (Drd-2)-deficient mice: do antipsychotics influence learning to ignore irrelevant stimuli via both Drd-2 and non-Drd-2 mechanisms?

Matthew J O'Callaghan, Cecilie Bay-Richter, Colm Mp O'Tuathaigh, David M Heery, John L Waddington, Paula M Moran

Open access · hybridAbstract read
In one paragraph

Article in Journal of psychopharmacology (Oxford, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Aberrant Salience Is Related to Reduced Reinforcement Learning Signals and Elevated Dopamine Synthesis Capacity in Healthy Adults.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Matthew J O'CallaghanSchool of Psychology, University of Nottingham, Nottingham, UK.
Cecilie Bay-RichterSchool of Psychology, University of Nottingham, Nottingham, UK present address: Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Colm Mp O'TuathaighMolecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland present address: School of Medicine, Brookfield Health Sciences Complex, University College Cork, Cork, Ireland.
David M HeerySchool of Pharmacy, Centre for Biomolecular Sciences, University of Nottingham, Nottingham, UK.
John L WaddingtonMolecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
Paula M MoranSchool of Psychology, University of Nottingham, Nottingham, UK paula.moran@nottingham.ac.uk.
University of Nottingham · GBAarhus University · DKRoyal College of Surgeons in Ireland · IEUniversity College Cork · IE

Funding

Wellcome Trust WT0845921Z
6 · The paper itself

Abstract

Whether the dopamine Drd-2 receptor is necessary for the behavioural action of antipsychotic drugs is an important question, as Drd-2 antagonism is responsible for their debilitating motor side effects. Using Drd-2 null mice (Drd2 -/-) it has previously been shown that Drd-2 is not necessary for antipsychotic drugs to reverse D-amphetamine disruption of latent inhibition (LI), a behavioural measure of learning to ignore irrelevant stimuli. Weiner's 'two-headed' model indicates that antipsychotics not only reverse LI disruption, 'disrupted LI', but also potentiate LI when low/absent in controls, 'persistent' LI. We investigated whether antipsychotic drugs haloperidol or clozapine potentiated LI in wild-type controls or Drd2 -/-. Both drugs potentiated LI in wild-type but not in Drd2 -/- mice, suggesting moderation of this effect of antipsychotics in the absence of Drd-2. Haloperidol potentiated LI similarly in both Drd1 -/- and wild-type mice, indicating no such moderation in Drd1 -/-. These data suggest that antipsychotic drugs can have either Drd-2 or non-Drd-2 effects on learning to ignore irrelevant stimuli, depending on how the abnormality is produced. Identification of the non-Drd-2 mechanism may help to identify novel non-Drd2 based therapeutic strategies for psychosis.

Indexed as

Inhibition, PsychologicalAnimalsAntipsychotic AgentsClozapineDopamine D2 Receptor AntagonistsHaloperidolLearningMiceMice, KnockoutReceptors, Dopamine D1Receptors, Dopamine D2Antipsychotic AgentsClozapineDopamine D2 Receptor AntagonistsHaloperidolReceptors, Dopamine D1Receptors, Dopamine D2AntipsychoticsclozapineDrd-2 knockout micehaloperidollatent inhibition

Identifiers

PMID25122042
PMCPMC4230883
OpenAlexW2134378898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.